相关实验视频
Updated: May 21, 2025

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
纳塔利祖马布在多发性硬化症中的药理动力学模型信息精确剂量
Stefan P H van den Berg1,2,3, Alyssa A Toorop4, Femke Hooijberg5
1Department of Immunopathology, Sanquin Research Amsterdam, Amsterdam, the Netherlands.
与标准方法相比,基于模型的精确剂量 (MIPD) 为多发性硬化症患者提供了一种更准确的方法来个性化纳塔利祖马布治疗间隔. 这种方法优化了药物暴露,减少了医院访问,并降低了医疗保健成本.
科学领域:
- 药理动力学和药理动力学
- 临床药理学 临床药理学
- 神经学 神经学
背景情况:
- 静脉注射纳塔利祖马布是复发性复发性多发性硬化症 (MS) 的关键治疗方法.
- 标准的4周剂量间隔可能不适合所有患者,可能导致治疗不足或过度治疗.
- 个性化剂量策略,包括治疗药物监测 (TDM),旨在优化纳塔利祖马布的疗效,减少医疗保健负担.
研究的目的:
- 评估基于模型的精确剂量 (MIPD) 的好处,以个性化纳塔利祖马布治疗间隔.
- 将MIPD的准确性和精度与TDM引导的分层个性化剂量 (SPD) 协议进行比较.
- 评估MIPD的可行性,以达到治疗性纳塔利祖马布的最低度和减少输液频率.
主要方法:
- 开发了一个新的 natalizumab.population药理动力学 (PK) 模型.
- 使用贝叶斯分析与患者体重和低谷度推导出个人PK估计.
- 将MIPD与基于决策树的SPD协议进行比较,用于个性化剂量间隔.
- 模拟MIPD以评估其对输液频率和药物暴露的影响.
主要成果:
- 与SPD协议相比,MIPD在预测最佳剂量间隔方面的准确性显著提高 (4.8%对10微克/毫升目标的24%;4.8%对5微克/毫升目标的86%).
- 此外,MIPD也显示出更高的精度 (RMSE 2.3与4.0为10μg/mL;1.5与5μg/mL为5μg/mL目标).
- 模拟表明MIPD可以将输注量减少40% (平均间隔7周),同时保持足够的药物暴露.
结论:
- 在MS中,MIPD优于传统的TDM指导的纳塔利祖马布个性化剂量.
- MIPD提高了选择单个剂量间隔的精度,允许更有效地延长治疗时间.
- 模拟支持MIPD用于纳塔利祖马布治疗的临床实施.
更多相关视频
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
相关概念视频
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Analysis of Population Pharmacokinetic Data